Skip to main content
PLOS One logoLink to PLOS One
. 2021 Apr 8;16(4):e0249738. doi: 10.1371/journal.pone.0249738

Cardiovascular disease subtypes, physical disability and workforce participation: A cross-sectional study of 163,562 middle-aged Australians

Muhammad Shahdaat Bin Sayeed 1,*, Grace Joshy 1, Ellie Paige 1, Emily Banks 1, Rosemary Korda 1
Editor: Thomas Behrens2
PMCID: PMC8031377  PMID: 33831054

Abstract

Background

Workforce participation is reduced among people with cardiovascular disease (CVD). However, detailed quantitative evidence on this is limited. We examined the relationship of CVD to workforce participation in older working-age people, by CVD subtype, within population subgroups and considering the role of physical disability.

Methods

Questionnaire data (2006–2009) for participants aged 45–64 years (n = 163,562) from the population-based 45 and Up Study (n = 267,153) were linked to hospitalisation data through the Centre for Health Record Linkage. Prior CVD was from self-report or hospitalisation. Modified Poisson regression estimated adjusted prevalence ratios (PRs) for non-participation in the workforce in people with versus without CVD, adjusting for sociodemographic factors.

Results

There were 19,161 participants with CVD and 144,401 without. Compared to people without CVD, workforce non-participation was greater for those with CVD (40.0% vs 23.5%, PR = 1.36, 95%CI = 1.33–1.39). The outcome varied by CVD subtype: myocardial infarction (PR = 1.46, 95%CI = 1.36–1.55); cerebrovascular disease (PR = 1.92, 95%CI = 1.80–2.06); heart failure (PR = 1.83, 95%CI = 1.68–1.98) and peripheral vascular disease (PR = 1.76, 95%CI = 1.65–1.88). Workforce non-participation in those with CVD versus those without was at least 21% higher in all population subgroups examined, with PRs ranging from 1.75 (95%CI = 1.65–1.85) in people aged 50–55 years to 1.21 (95%CI = 1.19–1.24) among those aged 60–64. Compared to people with neither CVD nor physical functioning limitations, those with physical functional limitations were around three times as likely to be out of the workforce regardless of CVD diagnosis; participants with CVD but without physical functional limitations were 13% more likely to be out of the workforce (PR = 1.13, 95%CI = 1.07–1.20).

Conclusions

While many people with CVD participate in the workforce, participation is substantially lower, especially for people with cerebrovascular disease, than for people without CVD, highlighting priority areas for research and support, particularly for people experiencing physical functioning limitations.

Introduction

Cardiovascular disease (CVD) remains a leading contributor to global burden of disease internationally [1] and is the second largest contributor to burden of disease in Australia [2], despite declining CVD mortality globally. With improving CVD survival, there is an increasing need to consider the consequences of living with CVD, for individuals and society. Many people with CVD are disabled to the extent that their core activities, including self-care, mobility, and communication are affected [3, 4], as is their ability to engage socially and participate in the workforce [5]. The effect of CVD on workforce participation is of particular importance. It not only affects the overall health and financial well-being of the person living with CVD [6], but also has consequences for society given the substantial economic benefits of retaining people in the workforce [7], an increasingly important issue as the population ages.

Studies outside Australia, primarily set in Europe, have shown that CVD is associated with poorer workforce outcomes, including higher rates of unemployment, exit from paid employment, receipt of disability pension and early retirement [813]. In Australia, studies have reported lower productivity in work [14], lower income [1517] and higher retirement due to ill-health [18] among people with CVD compared to those general population, but there is no large-scale comparative evidence on workforce participation in people with and without CVD. Furthermore, CVD is heterogeneous and there is a lack of comparative evidence on workforce participation across with different types of CVD and in different population subgroups. There is also limited information on why people with CVD may be less likely to participate in the workforce. In particular, although physical functional limitations are common among people with CVD [19] and are a key determinant of employment [20], no studies have examined the extent to which this might account for the lower workforce participation among people with CVD.

In this study we aimed to quantify workforce participation in a large Australian population-based study of 45-64-year-old men and women, comparing levels of non-participation in the workforce in people with versus without CVD, overall and according to CVD subtypes including ischaemic heart disease (IHD) and its subgroup myocardial infarction (MI), cerebrovascular disease, heart failure (HF) and peripheral arterial disease (PAD). We also aimed to examine whether the relationship between CVD and workforce participation varied by socio-demographic and health factors, and in particular, the extent to which co-existing physical functioning limitations–as a measure of physical disability–might explain differences in workforce participation between people with and without CVD. Such evidence is likely to be useful to inform CVD survivors, their care, policy and practice and in modelling CVD outcomes and costs.

Materials and methods

Study population and data sources

We used data from the Sax Institute’s 45 and Up Study, a population-based study of 267 153 people aged 45 and over in New South Wales (NSW) (~10% of the population in that age group), randomly sampled from the Medicare Australia database. Individuals joined the study by completing a postal questionnaire (available at https://www.saxinstitute.org.au/our-work/45-up-study/questionnaires/) and providing consent for follow-up through linkage to a range of routinely-collected data. The majority of participants were sampled in 2008 and the median baseline questionnaire date is February 2008. Persons aged 80 years and over and those living in rural and remote areas were oversampled by a factor of two. The response rate to mailed invitations was estimated to be 18%, representing around 10% of the NSW population aged 45 years and older [21]. This study used cross-sectional data from the baseline survey which included self-reported data from participants on socio-demographic, family, work and health. We also used linked data from the NSW Admitted Patient Data Collection to identify CVD diagnoses prior to study enrolment. The Admitted Patient Data Collection is a complete census of patients admitted to hospitals in NSW (available from 2001), covering public and private hospitals and private day procedure centres, and includes information on diagnosis, and procedures. The 45 and Up Study data and administrative health datasets were probabilistically linked through the Centre for Health Record Linkage (CHeReL) with false positive and negative rates of <0.5% and <0.1%, respectively. The participants with invalid data on age or date of recruitment (n = 454), those with linkage errors (n = 195) and those aged 65 years or over (n = 102,942) were excluded. There were 163,562 participants who were of working age (45-<65 years old) with known CVD status at baseline (70 458 men, 93 104 female) (details in S1-S4 Figs, S1-S3 Tables in S1 File).

Outcome: Workforce participation

The main outcome of interest was non-participation in paid work (yes/no). This was based on responses to the following two questions: “What is your current work status?” and “About how many hours each week do you usually spend doing the following—paid work, voluntary/unpaid work”?. Those indicating valid paid hours (> 0 and <100) or work status as at least one of “In full time paid work”, “In part time paid work”, “Self-employed”, “Partially retired” were classified as participating in the workforce; of the remaining participants, those indicating work status as “Doing unpaid work”, “Completely retired/pensioner”, “Studying”, “Looking after home/family”, “Disabled/sick”, “Unemployed”, “Other” were classified as not participating in the workforce.

Secondary outcomes included paid work hours/week among those in paid work, retirement (yes/no), and retirement due to ill-health (yes/no) among those not in paid work. Paid work hours/week was defined based on responses to the following questions: “What is your current work status?” and “About how many hours each week do you usually spend doing the following?—paid work, voluntary/unpaid work”. Zero or non-zero positive values less than 100 were considered valid paid hours per week. Further logical checks was applied with workforce participation status variable (S4 Table in S1 File).

Retirement was defined from question that asked ‘If you are partially or completely retired, why did you retire?’. Participants with valid records for any of the options (“Reached usual retirement age”, “Lifestyle reasons”, “To care for family members/friend”, “Ill health”, “Made redundant”, “Made redundant”, “Could not find a job”, “Other”) were defined as ‘retired’ and those without any of these options were defined as ‘not retired’. Following logical checks, participants not in the work force were classified as “yes (retired due to ill health)” if they chose “ill health”, and otherwise as “no (retired for other reasons)”.

Further outcome specific exclusions for missing or invalid data applied for each outcome. Among the 163,562 participants included in the study, 131 had missing data on workforce participation status. Of the 121,816 participants in the work force, 7752 had missing/invalid data on the number of paid hours per week and of the 41,615 participants not in the work force, 11,961 had invalid data on retirement due to ill health (S1 Fig in S1 File).

Main exposure: Cardiovascular disease

Participants were classified as either having CVD or not. CVD was defined as self-reported heart disease, stroke or blood clot on the baseline questionnaire, or at least one hospital admission in the five years prior to entering the study with a major CVD diagnosis code, as identified in any diagnostic or a procedure code fields in the linked hospital admissions data (details in S5 Table in S1 File) [22]. A five-year window was used to ensure uniform probability of identification of previous diagnoses from administrative data for all participants. We also sub-categorised participants based on hospitalisations for the following CVD subtypes (yes/no): IHD (ICD-AM codes: I20-I25), MI (ICD-AM codes: I21, I22 and I23), cerebrovascular disease (ICD-AM codes: I61, I63, I64), PAD (ICD-AM codes: I70-I74) and HF (ICD-AM codes: I50, I11.0, I13.0, I13.2). The ‘other CVD’ group consisted of those participants with CVD who had self-reported CVD or any CVD codes other than the CVD subtype as mentioned earlier. The participants with hospitalisation for a particular CVD subtype may or may not have had another types of CVD hospitalisations. In the sensitivity analyses, we further stratified people with CVD into self-reported CVD only, CVD hospitalisation only or both, and in combination of several CVD subtype where sample size permitted.

Other variables of interest

Sociodemographic and health variables known to be associated with workforce participation [2332], were used to define population subgroups. The sociodemographic variables included: age, sex, remoteness of residence (categorised as major cities, inner regional and more remote), marital status (categorised as married/defacto and single/widowed/divorced), education attainment (categorised as tertiary, certificates/diploma/trade and high school or less), language spoken at home other than English (LOTE) (yes/no) and born in Australia/New Zealand (yes/no). The health-related variables included: body mass index (BMI, kg/m2) categorised as underweight (15-<18.5), normal weight (18.5-<25), overweight (25-<30), obese (30–50); alcohol consumption (number of alcoholic drinks per week categorised as non-drinkers (zero drinks per week), moderate drinkers (>0-<15 drinks per week), heavy drinkers (≥15 drinks per week)); smoking status (non-smoker, past-smoker, current smoker); self-reported doctor-diagnosed diabetes/cancer/osteoarthritis (yes/no for each) and physical functioning limitations. The cut-points of alcohol consumption broadly reflect Australian guidelines on low-risk consumption [33]. Physical functioning limitations were assessed using the Medical Outcomes Study–Physical Functioning (MOS-PF) subscale which was based on 10 questionnaire items assessing varying levels of physical functioning [34]. Physical functioning limitations scores ranged from 0 to 100, with higher scores representing fewer limitations, and were grouped into four categories: no limitation (score of 100); minor limitation (score 90–99); moderate limitation (60–89); and severe limitation (score 0–59) [35] (details in S6 Table in S1 File). These variables were based on the self-reported data from the baseline survey (2006–2009) of the 45 and Up Study, except for sex (obtained from Medicare Australia database [21]) and remoteness of residence (derived from the mean Accessibility Remoteness Index of Australia Plus score [36]).

Statistical analysis

Descriptive statistics were used to summarise characteristics of the study population and distribution of outcomes by CVD status. Modified Poisson regression with robust error variance [37] was used to estimate prevalence ratios (PRs) for non-participation in the paid workforce in relation to CVD. Models were sequentially adjusted, initially adjusting for age-group (5-year age bands) and sex [model 1], noting no sex by CVD interaction was observed, and then additionally adjusted for region of residence and education [model 2]. Further statistical adjustments were not done as the objective was to compare prevalences and lived experiences; causality cannot be established in this cross-sectional analysis. We also estimated PRs separately within population subgroups; chi-square tests for heterogeneity were used to assess heterogeneity between subgroups. To examine the potential contribution of physical functioning to the CVD-workforce participation relationship, we modelled the joint categorisation of CVD and physical functioning limitations on workforce participation; those with no CVD and no physical functioning limitations were used as the reference group. Participants with missing values for workforce participation were excluded from all analyses. There were no missing data in the main exposure (CVD status), age or sex. Missing values for the factors used in the model adjustments were included in the analysis as separate categories.

Self-reported CVD and hospital recorded CVD was considered separately in the first sensitivity analysis, the hospital recorded CVD subtypes were considered after excluding participants with multiple CVD subtypes in the second sensitivity analysis, and combination of more than one CVD subtypes in the third sensitivity analysis.

In supplementary analysis, the PRs for retirement and retirement due to ill health were estimated using similar methods as those for non-participation in paid workforce, and a generalised linear model assuming a Poisson distribution and log link function was used to estimate mean of paid work hours per week.

Analyses was carried out using SAS software version 9.4 and R version 3.5.2 [38].

Ethics approval

Individuals gave written informed consent to take part in the study, including consent for linkage of their data to population health databases. The conduct of the 45 and Up Study was approved by the University of New South Wales Human Research Ethics Committee (HREC). Ethics approval for this project was obtained from the NSW Population and Health Services Research Ethics Committee (Reference: HREC/12/CIPHS/31) and the Australian National University Human Research Ethics Committee (Reference: 2012/504).

Results

Characteristics of the study participants

There were 163,562 study participants: 19,161 (11.7%) with CVD and 144,401 (88.3%) without CVD. 121,816 participants (74.5%) were in the paid workforce, of whom 11,480 (9.4%) had CVD; and 155,723 participants (>95%) had valid paid work hours per week (i.e. ≥ 0 and <100). There were 43,397 participants who had retired, 29,654 of retirees had not been working in any form and 5,970 of whom had CVD (20.1%). The sociodemographic profile of participants with and without CVD was similar except that the CVD group had higher proportions of men and older participants (Table 1). Participants with CVD had a poorer health profile than those without CVD, with higher levels of smoking, obesity, comorbid diseases and moderate/severe functional limitation (Table 1).

Table 1. Sociodemographic and health related characteristics of study participants.

People with CVD People without CVD
Total participants (n = 163562) 19161 144401
Percentage (%) 11.7 (19161/ 163562) 88.3 (144401/ 163562)
Age (years)
Mean (sd) 57.5 (5.18) 55.0 (5.38)
 45–49 11.0 (2110) 22.7 (32759)
 50–54 19.7 (3767) 27.1 (39173)
 55–59 29.8 (5712) 27.5 (39733)
 60–64 39.5 (7572) 22.7 (32736)
Sex
 Men 51.5 (9873) 42.0 (60585)
 Women 48.5 (9288) 58.0 (83816)
Region of residence
 Major cities 49.5 (9477) 51.9 (75002)
 Inner regional 36.1 (6911) 34.7 (50058)
 More remote 12.4 (2370) 11.4 (16392)
Marital status
 single/widowed/separated 23.1 (4425) 20.1 (29042)
 Married/defacto 76.3 (14613) 79.3 (114549)
Education attainment
 No school certificate 12.8 (2460) 7.8 (11225)
 Certificate/diploma/trade 64.1 (12277) 62.3 (89897)
 Tertiary 22.0 (4206) 29.0 (41853)
Language spoken at home other than English (Yes) 8.5 (1623) 10.0 (14443)
Country of birth in Australia/NZ 79.6 (15244) 78.0 (112655)
Alcohol consumption
 None (0 drink per week) 34.5 (6604) 28.9 (41680)
 Moderate drinkers (1-14drinks per week) 48.2 (9237) 54.6 (78857)
 Heavy drinkers (15 or more drinks per week) 15.6 (2988) 15.1 (21793)
Smoking status
 Current 10.7 (2046) 9.3 (13367)
 Past 40.9 (7839) 33.0 (47590)
 Never 48.0 (9194) 57.5 (82979)
BMI Category
 Underweight (15-<18.5) 0.9 (169) 0.9 (1369)
 Normal weight (18.5-<25) 24.3 (4659) 34.7 (50047)
 Overweight (25-<30) 36.3 (6959) 36.1 (52120)
 Obese (30 to 50) 31.3 (6005) 21.6 (31159)
Medical History: Cancer: Yes 15.2 (2919) 10.7 (15416)
Medical History: Diabetes: Yes 14.4 (2753) 5.4 (7804)
Medical History: Osteoarthritis: Yes 4.8 (921) 2.8 (4026)
Physical functioning limitations
No limitation 22.7 (4347) 41.7 (60166)
Minor limitation 24.6 (4714) 26.7 (38603)
Moderate limitation 24.2 (4645) 16.1 (23275)
Severe limitation 18.5 (3536) 6.1 (8812)

Note: % missing responses (CVD, No CVD): region of residence (2.1, 2); marital status (0.6, 0.6); education attainment (1.1, 1), country of birth (0.8, 0.8), alcohol per week (1.7, 1.4); smoking status (0.4, 0.3); BMI (7.1, 6.7); physical functioning limitations (10.0, 9.4). sd refers to standard deviation, NZ refers to New Zealand, BMI refers to Body Mass Index.

CVD and workforce participation

Overall, 60% of people with CVD were participating in the workforce, compared to 76% of people without CVD (Table 2). Mean weekly working hours per week among those in paid work was slightly lower overall for people with CVD than without CVD. Of all participants, 42% of people with CVD had retired, compared to 25% of people without CVD. Of the retirees who were not in paid workforce in any form, 53% of people with CVD had retired due to ill health, compared to 26% of people without CVD. In every 5-year age bracket (45-<50 to 60-<65), non-participation was higher, weekly work hours slightly lower, retirement and retirement due to ill health higher in men and women with CVD than without CVD (Fig 1).

Table 2. Workforce participation, paid work hours per week, retirement patterns and physical functioning limitations among study participants.

People with CVD People without CVD
Total N 19161 144401
In workforce* 59.9 (11480) 76.4 (110336)
  In full time paid work 28.0 (5358) 38.8 (55971)
  Self-employed 14.0 (2675) 17.3 (24913)
  In part time paid work 15.4 (2950) 19.7 (28512)
  Partially retired 6.8 (1297) 5.3 (7644)
Not in workforce 40.0 (7657) 23.5 (33958)
  Doing unpaid work 5.8 (1102) 5.3 (7681)
  Completely retired/pensioner 21.5 (4113) 12.3 (17729)
  Studying 1.7 (319) 2.1 (3053)
  Looking after home/family 9.9 (1902) 11.2 (16182)
  Disabled/sick 14.9 (2859) 4.4 (6410)
  Unemployed 3.8 (732) 3.1 (4502)
  Other 2.0 (380) 1.7 (2419)
Paid hours of work (for those in workforce)
  N 10506 103558
  Mean, SD 34.9, 15.6 35.9, 14.8
  Median [inter quartile range] 38 [25, 45] 38 [26, 45]
Retirement reasons (among those who retired and not in the workforce)
Total N 5970 23684
Retired due to ill health 53.0 (3166) 26.3 (6238)
Retired due to other reasons 47.0 (2804) 73.7 (17446)
  Reached usual retirement age 7.9 (474) 12.2 (2896)
  Lifestyle reasons 20.7 (1237) 32.4 (7684)
  To care for family member/friend 10.9 (648) 14.9 (3537)
  Made redundant 10.6 (630) 11.7 (2770)
  Could not find a job 5.6 (332) 5.4 (1277)
  Other 9.8 (584) 14.1 (3328)

One person might be in more than one category of sub-groups of those in workforce, not in workforce and retired due to other reasons.

*% missing responses of workforce participation (Total, CVD, No CVD): (0.08, 0.13, 0.07).

Fig 1. Workforce participation characteristics among study participants according to CVD status, sex and age-group.

Fig 1

After adjusting for sociodemographic characteristics (age, sex, region of residence and education), workforce non-participation was 36% higher among people with any CVD compared to people without CVD [prevalence ratio (PR) = 1.36 (95% CI: 1.33–1.39)]. Workforce non-participation varied by CVD subtype, with PRs of 1.46 (95% CI: 1.41–1.50) for IHD and 1.92 (95% CI: 1.80–2.06) for cerebrovascular disease (Fig 2). Sensitivity analysis indicate that those with CVD hospitalisation had somewhat higher PRs of non-participation in the paid workforce compared to those with self-reported CVD only (S7 Table in S1 File) and people with only one type of CVD had slightly lower PRs of non-participation in the paid workforce than those with more than one type of CVD (S8 and S9 Tables in S1 File). A similar pattern of results was seen for work hours among those who are in paid workforce, retirement among all participants and retirement due to ill health of retirees who had not been working in any form (S5-S7 Figs, S10-S18 Tables in S1 File).

Fig 2. Non-participation in the workforce: Prevalence and adjusted prevalence ratios in people with and without CVD and according to hospitalisation for CVD subtypes.

Fig 2

CVD and workforce participation among population subgroups

Workforce participation was associated with a number of sociodemographic factors among both people with and without CVD, including age, marital status, education, country of birth, alcohol consumption, smoking status and having medical history of osteoarthritis (Fig 3, S8 and S9 Figs in S1 File). When workforce participation was compared in people with and without CVD within sociodemographic and health subgroups, workforce non-participation remained higher among people with CVD compared to those without CVD, regardless of population subgroup. However, PRs were significantly higher among younger people, men, those who were not married/de facto, those without tertiary qualifications and those who were current smokers. Although the absolute crude prevalence of workforce non-participation was higher in older compared to younger age groups (irrespective of CVD status), the relation of CVD and workforce non-participation became weaker with increasing age (Fig 3).

Fig 3. Prevalence ratio of not in workforce in population subgroups based on socio-demographic and health related factors.

Fig 3

CVD, physical functioning limitations and workforce participation

Workforce participation was lower in those with greater physical functional limitations—among both those with and without CVD—but non-participation was higher among those with CVD in all sub-groups based on physical functioning limitations (Fig 4). Among participants with no physical functioning limitations, about one in 5 were not working—21% of those with CVD and 16% of those without CVD; among participants with severe functioning limitations, 73% of those with CVD, and 60% of those without CVD, were not working. After adjustment for sociodemographic variables, compared to those without CVD and no functional limitations, participants without physical functional limitations but with CVD were 13% more likely to be out of the workforce (PR = 1.13, 95%CI = 1.07–1.20). Those with severe functioning limitations were 3 times as likely to be out of the workforce if they had CVD [PR = 2.91 (95% CI: 2.82–3.00)] and 2.7 times as likely if they did not have CVD [PR = 2.70 (95% CI: 2.63–2.77)] (Fig 4).

Fig 4. Non-participation in the workforce: Prevalence and adjusted prevalence ratios according to joint categories of physical functioning limitations and CVD.

Fig 4

Discussion

In this large population-based Australian study of older working-age adults, people with CVD were around 36% more likely than those without CVD to be out of the workforce. Non-participation was highest for people with cerebrovascular disease, peripheral arterial disease and heart failure and lowest for other types of CVD. Lower workforce participation among people with CVD was evident regardless of age, sex and other sociodemographic and health-related characteristics. Importantly, physical functioning was strongly related to workforce participation, and in people without physical functioning limitations, participation rates in those with and without CVD were similar, while people with CVD and severe physical functioning limitations were almost three times as likely as those without CVD and no functional limitations to not to be in paid work.

We know of no other studies in Australia that have compared workforce participation in people with and without CVD using large-scale population data. Our study results are broadly comparable to studies set in Canada, Japan, and Europe, which have consistently shown that people with CVD are less likely to participate in the workforce than people without CVD [12, 23, 39]. It is somewhat difficult to compare the magnitude of our findings with these studies, given the variation in study design, definition of workforce participation, case definition of CVD, and selection of the comparison population. For example, a cross-sectional investigation with a study population from 10 European countries found that people with stroke had a 11% higher odds of being unemployed [23] compared to those without stroke. A study with participants in France with stroke were 50% more likely to be out of workforce [12]. The magnitude of the association between stroke and workforce participation from these European studies was lower than the 92% increase in odds of being out of the workforce for those with vs. without cerebrovascular disease in our study.

We could not find any other study that reported workforce participation in absolute and relative terms among different population sub-groups based on sociodemographic and health-related factors. Similar to a previous report [23], our results indicate that women were more likely to be out the paid workforce compared to men in absolute terms, but the magnitude of the relative association between CVD and workforce participation was greater among men than women. We could not find other study to compare our findings that people with CVD who were single, had education less than tertiary education or were current smokers were more likely in absolute and relative terms to be out of the workforce compared to those without CVD. However, there were some studies to compare the secondary outcomes in our investigations but those varied by countries of the previously reported studies. For example, participants in Italy with MI had 50% higher chance to retire early [24], compared to 27% in our study. Previous studies from 10 European countries have reported on the extent on early retirement of people with CVD subtype such as stroke [23] but comparison could not be made due to variation in the definition of the CVD subtype as indicated in this study.

While our study, like others, highlights the relatively high prevalence of workforce non-participation among people with CVD and a stronger relationship in younger people is also consistent with the idea that CVD is the driving force, it should not be assumed that CVD is the cause without additional evidence. However, cohort studies in Europe and Canada provide evidence consistent with a casual explanation [811, 13, 40, 41]. For example, one study from the Netherlands analysed various exit mechanisms from paid employment (such as, via unemployment benefits, via early retirement benefits etc.) and reported that in comparison to those without CVD, people with incident CVD were more likely to leave paid employment regardless of the exit mechanisms [41]. Nevertheless, the relationship between CVD and workforce participation, particularly when measured in terms of government benefits, is highly specific to the social welfare structure of the countries in which study participants live and work. In other studies, risk of leaving employment increased with severe CVD subtypes such as coronary heart disease, stroke and MI [911, 13, 40] which are also broadly similar to those reported in our investigation, especially participants living with multiple CVD subtype. Another underlying reason for higher workforce non-participation in people with CVD could be physical disability since physical functioning has been shown to decline following incident CVD [41] and this study has indicated that those with higher physical functioning limitations had the highest probability of being out of paid-work.

This key finding, that impaired physical functioning is likely to be an important factor underpinning the difference in workforce participation rates between those with and without CVD, has not been reported previously. However, it is consistent with the evidence from a European study reporting a relatively high proportion of people with CVD leave the paid workforce via disability pension [42] compared those without CVD. This may also explain the lower participation rates among people with cerebrovascular disease, peripheral artery disease and heart failure compared to those with ischemic heart disease. This is an important finding as cardiac rehabilitation programs help improve physical functional limitations [43] and hence may improve return to work.

Our large-scale population-based study with linkage to hospital records allowed comparison of workforce non-participation in people with and without CVD, within population subgroups and across CVD subtypes enabling a comprehensive comparative description of workforce participation in individuals living with CVD in the community. However, there was a lack of information on the types of work people were engaged in. This would have been valuable in better understanding the observed workforce participation patterns. Our study population was randomly sampled from a whole-of-population database, and included ~ 10% of the entire population in the target age-group and the response rate was ~18%, consistent with cohort studies of this nature. Generally, participants in cohort studies are healthier than the general population [44]. Though we could not find a comparable age-group similar ours for prevalence of CVD in Australia, the workforce participation rate in our study was 9% higher (74.6% vs 65.2%), than that reported for Australia for the same age group during the same period (2007–08) by the Australian Bureau of Statistics [45, 46]. Hence, while our absolute estimates of CVD prevalence and workforce participation may not be directly representative, PRs, which are based on internal comparisons, are still likely to be generalisable [47].

More precise point estimates of the workforce participation among people with CVD in Australia may be derived from linked administrative data, which do not rely on survey participation. In future, longitudinal investigation of change in workforce participation in Australia after incident CVD would be valuable for enhancing our understanding about the transitions in workforce participation in relation to major CVD events. Our results show the majority of people with CVD were still in the paid workforce but people who have experienced a CVD event, especially those with physical disability, were more vulnerable to not being in the workforce compared to their counterparts. Given the important of paid work for mental health and overall economy [15], policies aiming to help people with CVD or other major illness remain or re-enter the workforce could help lessen this gap. Thus, our findings will be valuable for healthy and successful aging for those with CVD.

Conclusion

While the majority of people with CVD continue to undertake paid work, participation is reduced compared to people without CVD. Lower participation was observed for different CVD subtypes and among different population sub-groups, and workforce non-participation was relatively higher for people who had had a stroke, heart failure or peripheral vascular disease, who were in their 50s. Physical functioning limitations was a key factor in non-participation in the paid workforce both for those with and without CVD. Similar associations were observed for weekly paid work hours among those who had been working, retirement among all study participants and retirement due ill health among retirees who had not been working. The results of this investigation have significant policy implications for healthy and successful ageing for those living with CVD. It underpins the importance of rehabilitation and suggests that social policies to encourage employment among older persons should integrate consideration of the role of chronic disease, including CVD.

Supporting information

S1 File

(DOCX)

Acknowledgments

This research was completed using data collected through the 45 and Up Study (www.saxinstitute.org.au). The 45 and Up Study is managed by the Sax Institute in collaboration with major partner Cancer Council NSW; and partners: the National Heart Foundation of Australia (NSW Division); NSW Ministry of Health; NSW Government Family & Community Services–Ageing, Carers and the Disability Council NSW; and the Australian Red Cross Blood Service. We thank the many thousands of people participating in the 45 and Up Study.

Data Availability

This study uses data from the 45 and Up Study, which is managed by the Sax Institute in collaboration with major partner Cancer Council NSW, and partners: the National Heart Foundation of Australia (NSW Division); NSW Ministry of Health; NSW Government Family & Community Services–Ageing, Carers and the Disability Council NSW; and the Australian Red Cross Blood Service. Data supporting the findings from this study are available from the Sax Institute, the NSW Department of Health and the Australian Bureau of Statistics, with data linkage conducted by the NSW Centre for Health Record Linkage. Restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Researchers may apply for access to these data with the appropriate data custodian and ethics approvals. Information about data access and governance policies is available at: https://www.saxinstitute.org.au/our-work/45-up-study/for-researchers/.

Funding Statement

Muhammad Shahdaat Bin Sayeed is supported by an Australian Government Research and Training scholarship to undertake a PhD at the Australian National University, Canberra, ACT, Australia. Emily Banks is supported by a Principal Research Fellowship from the National Health and Medical Research Council of Australia (reference 1136128). Ellie Paige is supported by a Postdoctoral Fellowship (reference: 102131) from the National Heart Foundation of Australia. This project was supported by a Project Grant from the National Health and Medical Research Council of Australia (reference 1139539).

References

  • 1.Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, et al. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1–25. 10.1016/j.jacc.2017.04.052 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.AIHW. Australian health expenditure—demographics and diseases: hospital admitted patient expenditure 2004–05 to 2012–13. Australia: AIHW, 2017 23 Oct 2017. Report No.: Contract No.: Cat. no. HWE 69. Canberra: AIHW.
  • 3.AIHW. Australian Institute of Health and Welfare 2016. Australia’s health 2016. Australia’s health series no. 15.Cat. no. AUS 199. Canberra: AIHW. 2016.
  • 4.Jonsson B. Measurement of health outcome and associated costs in cardiovascular disease. Eur Heart J. 1996;17 Suppl A:2–7. 10.1093/eurheartj/17.suppl_a.2 [DOI] [PubMed] [Google Scholar]
  • 5.AIHW. Australian Institute of Health and Welfare 2009. Chronic disease and participation in work. Cat. no. PHE 109. Canberra: AIHW. 2009.
  • 6.Goodman N. The impact of employment on the health status and health care costs of working-age people with disabilities. LEAD Center Policy Brief, Retrieved on 8 Dec, 2019. http://www.leadcenter.org/system/files/resource/downloadable_version/impact_of_employment_health_status_health_care_costs_0.pdf2015.
  • 7.AustralianNetworkonDisability. The economic benefits of increasing employment for people with disability, Commissioned by the Australian Network on Disability (AND), retrieved December 8, 2019. https://www.and.org.au/data/Conference/DAE_Report_8May.pdf: Australian Network on Disability (AND), 2011.
  • 8.Garland A, Jeon SH, Stepner M, Rotermann M, Fransoo R, Wunsch H, et al. Effects of cardiovascular and cerebrovascular health events on work and earnings: a population-based retrospective cohort study. CMAJ. 2019;191(1):E3–e10. 10.1503/cmaj.181238 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Kouwenhoven-Pasmooij TA, Burdorf A, Roos-Hesselink JW, Hunink MG, Robroek SJ. Cardiovascular disease, diabetes and early exit from paid employment in Europe; the impact of work-related factors. Int J Cardiol. 2016;215:332–7. 10.1016/j.ijcard.2016.04.090 [DOI] [PubMed] [Google Scholar]
  • 10.Kruse M, Sorensen J, Davidsen M, Gyrd-Hansen D. Short and long-term labour market consequences of coronary heart disease: a register-based follow-up study. Eur J Cardiovasc Prev Rehabil. 2009;16(3):387–91. 10.1097/HJR.0b013e32832a3333 [DOI] [PubMed] [Google Scholar]
  • 11.Maaijwee N, Rutten-Jacobs LCA, Arntz RM, Schaapsmeerders P, Schoonderwaldt HC, van Dijk EJ, et al. Long-term increased risk of unemployment after young stroke A long-term follow-up study. Neurology. 2014;83(13):1132–8. 10.1212/WNL.0000000000000817 [DOI] [PubMed] [Google Scholar]
  • 12.Schnitzler A, Jourdan C, Josseran L, Azouvi P, Jacob L, Genet F. Participation in work and leisure activities after stroke: A national study. Ann Phys Rehabil Med. 2019;62(5):351–5. 10.1016/j.rehab.2019.04.005 [DOI] [PubMed] [Google Scholar]
  • 13.Smedegaard L, Nume AK, Charlot M, Kragholm K, Gislason G, Hansen PR. Return to Work and Risk of Subsequent Detachment From Employment After Myocardial Infarction: Insights From Danish Nationwide Registries. J Am Heart Assoc. 2017;6(10). 10.1161/JAHA.117.006486 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Holden L, Scuffham PA, Hilton MF, Ware RS, Vecchio N, Whiteford HA. Which health conditions impact on productivity in working Australians? J Occup Environ Med. 2011;53(3):253–7. 10.1097/JOM.0b013e31820d1007 [DOI] [PubMed] [Google Scholar]
  • 15.Schofield D, Shrestha R, Percival R, Passey M, Callander E, Kelly S. The personal and national costs of CVD: impacts on income, taxes, government support payments and GDP due to lost labour force participation. Int J Cardiol. 2013;166(1):68–71. 10.1016/j.ijcard.2011.09.066 [DOI] [PubMed] [Google Scholar]
  • 16.Schofield DJ, Callander EJ, Shrestha RN, Percival R, Kelly SJ, Passey ME. Labour force participation and the influence of having CVD on income poverty of older workers. Int J Cardiol. 2012;156(1):80–3. 10.1016/j.ijcard.2011.03.020 [DOI] [PubMed] [Google Scholar]
  • 17.Callander EJ, Schofield DJ. The risk of falling into poverty after developing heart disease: a survival analysis. BMC Public Health. 2016;16:570. 10.1186/s12889-016-3240-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Paradise MB, Naismith SL, Davenport TA, Hickie IB, Glozier NS. The impact of gender on early ill-health retirement in people with heart disease and depression. The Australian and New Zealand journal of psychiatry. 2012;46(3):249–56. 10.1177/0004867411427807 [DOI] [PubMed] [Google Scholar]
  • 19.Britton A, Brunner E, Kivimaki M, Shipley MJ. Limitations to functioning and independent living after the onset of coronary heart disease: what is the role of lifestyle factors and obesity? Eur J Public Health. 2012;22(6):831–5. 10.1093/eurpub/ckr150 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.AIHW. Australian Institute of Health and Welfare 2019. People with disability in Australia 2019: in brief. Cat. no. DIS 74. Canberra: AIHW. 2019.
  • 21.Banks E, Redman S, Jorm L, Armstrong B, Bauman A, Beard J, et al. Cohort profile: the 45 and up study. International journal of epidemiology. 2008;37(5):941–7. 10.1093/ije/dym184 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Joshy G, Korda RJ, Abhayaratna WP, Soga K, Banks E. Categorising major cardiovascular disease hospitalisations from routinely collected data. Public Health Res Pract. 2015;25(3):e2531532. 10.17061/phrp2531532 [DOI] [PubMed] [Google Scholar]
  • 23.Alavinia SM, Burdorf A. Unemployment and retirement and ill-health: a cross-sectional analysis across European countries. Int Arch Occup Environ Health. 2008;82(1):39–45. 10.1007/s00420-008-0304-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Li Ranzi T, d’Errico A, Costa G. Association between chronic morbidity and early retirement in Italy. Int Arch Occup Environ Health. 2013;86(3):295–303. 10.1007/s00420-012-0765-5 [DOI] [PubMed] [Google Scholar]
  • 25.Blake HL, McLeod S, Verdon S, Fuller G. The relationship between spoken English proficiency and participation in higher education, employment and income from two Australian censuses. Int J Speech Lang Pathol. 2018;20(2):202–15. 10.1080/17549507.2016.1229031 [DOI] [PubMed] [Google Scholar]
  • 26.Jørgensen MB, Pedersen J, Thygesen LC, Lau CJ, Christensen AI, Becker U, et al. Alcohol consumption and labour market participation: a prospective cohort study of transitions between work, unemployment, sickness absence, and social benefits. Eur J Epidemiol. 2019;34(4):397–407. 10.1007/s10654-018-0476-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Norrbäck M, Tynelius P, Ahlström G, Rasmussen F. The association of mobility disability and obesity with risk of unemployment in two cohorts from Sweden. BMC public health. 2019;19(1):347. 10.1186/s12889-019-6627-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Webber DA, Bjelland MJ. The Impact of Work-Limiting Disability on Labor Force Participation. 2015;24(3):333–52. 10.1002/hec.3020 [DOI] [PubMed] [Google Scholar]
  • 29.Majeed T, Forder PM, Tavener M, Vo K, Byles J. Work after age 65: A prospective study of Australian men and women. Australasian journal on ageing. 2017;36(2):158–64. 10.1111/ajag.12382 [DOI] [PubMed] [Google Scholar]
  • 30.Majeed T, Forder P, Mishra G, Kendig H, Byles J. A gendered approach to workforce participation patterns over the life course for an Australian baby boom cohort. J. Vocat. Behav. 2015;87:108–22. [Google Scholar]
  • 31.Korda RJ, Soga K, Joshy G, Calabria B, Attia J, Wong D, et al. Socioeconomic variation in incidence of primary and secondary major cardiovascular disease events: an Australian population-based prospective cohort study. Int J Equity Health. 2016;15(1):189. 10.1186/s12939-016-0471-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Paige E, Welsh J, Agostino J, Calabria B, Banks E, Korda RJ. Socioeconomic variation in absolute cardiovascular disease risk and treatment in the Australian population. Prev Med. 2018;114:217–22. 10.1016/j.ypmed.2018.07.011 [DOI] [PubMed] [Google Scholar]
  • 33.NHMRC (National Health and Medical Research Council). Australian guidelines to reduce health risks from drinking alcohol (NHMRC, Canberra, 2009). [Google Scholar]
  • 34.Haley SM, McHorney CA, Ware JE. Evaluation of the mos SF-36 physical functioning scale (PF-10): I. Unidimensionality and reproducibility of the Rasch Item scale. J Clin Epidemiol. 1994;47(6):671–84. 10.1016/0895-4356(94)90215-1 [DOI] [PubMed] [Google Scholar]
  • 35.Gubhaju L, Banks E, MacNiven R, McNamara BJ, Joshy G, Bauman A, et al. Physical Functional Limitations among Aboriginal and Non-Aboriginal Older Adults: Associations with Socio-Demographic Factors and Health. PLoS One. 2015;10(9):e0139364. 10.1371/journal.pone.0139364 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.AIHW. Australian Institute of Health and Welfare 2004. Rural, regional and remote health: A guide to remoteness classifications Cat. no. PHE 53. Canberra: AIHW. 2004;53.
  • 37.Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702–6. 10.1093/aje/kwh090 [DOI] [PubMed] [Google Scholar]
  • 38.Team RC. R: A language and environment for statistical computing. 2013. [Google Scholar]
  • 39.Nakaya N, Nakamura T, Tsuchiya N, Tsuji I, Hozawa A, Tomita H. Unemployment risk among individuals undergoing medical treatment for chronic diseases. Occup Med (Lond). 2016;66(2):143–9. 10.1093/occmed/kqv159 [DOI] [PubMed] [Google Scholar]
  • 40.Feigl AB, Goryakin Y, Devaux M, Lerouge A, Vuik S, Cecchini M. The short-term effect of BMI, alcohol use, and related chronic conditions on labour market outcomes: A time-lag panel analysis utilizing European SHARE dataset. PLoS One. 2019;14(3):e0211940. 10.1371/journal.pone.0211940 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Kucharska-Newton A, Griswold M, Yao ZH, Foraker R, Rose K, Rosamond W, et al. Cardiovascular Disease and Patterns of Change in Functional Status Over 15 Years: Findings From the Atherosclerosis Risk in Communities (ARIC) Study. J Am Heart Assoc. 2017;6(3):e004144. 10.1161/JAHA.116.004144 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Oude Hengel K, Robroek SJW, Eekhout I, Van Der Beek AJ, Burdorf A. Educational inequalities in the impact of chronic diseases on exit from paid employment among older workers: A 7-year prospective study in the Netherlands. Occup Environ Med. 2019;76(10):718–25. 10.1136/oemed-2019-105788 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Audelin MC, Savage PD, Ades PA. Exercise-based cardiac rehabilitation for very old patients (≥75 Years): focus on physical function. J Cardiopulm Rehabil Prev. 2008;28(3):163–73. 10.1097/01.HCR.0000320066.58599.e5 [DOI] [PubMed] [Google Scholar]
  • 44.Ramirez-Santana M. Limitations and Biases in Cohort Studies. Cohort Studies in Health Sciences. Mauricio Barría R., IntechOpen, 2018. Available from: https://www.intechopen.com/books/cohort-studies-in-health-sciences/limitations-and-biases-in-cohort-studies 10.5772/intechopen.74324 [DOI] [Google Scholar]
  • 45.AIHW. Australian Institute of Health and Welfare 2011. Cardiovascular disease: Australian facts 2011. Cardiovascular disease series. Cat. no. CVD 53. Canberra: AIHW. 2011.
  • 46.ABS. Australian Bureau of Statistics, Labour force, Australia, May 2008. Cat. no. 6202.0. 2008.
  • 47.Mealing NM, Banks E, Jorm LR, Steel DG, Clements MS, Rogers KD. Investigation of relative risk estimates from studies of the same population with contrasting response rates and designs. BMC Med Res Methodol. 2010;10:26. 10.1186/1471-2288-10-26 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Thomas Behrens

25 Nov 2020

PONE-D-20-33041

Cardiovascular disease subtypes, physical disability and workforce participation: a cross-sectional study of 163,562 middle-aged Australians

PLOS ONE

Dear Dr. Bin Sayeed,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. You find our reviewers' comments below.

Please submit your revised manuscript by Jan 09 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Thomas Behrens

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

3. Thank you for stating the following in your Competing Interests section: 

'None'

a. Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now

b. This information should be included in your cover letter; we will change the online submission form on your behalf.

Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors examined the relationship of cardiovascular disease to workforce participation in older working-age people. For this purpose they used questionnaire data from a very large population based study assessed between 2006 and 2009 in New South Wales (Australia) and linked it to hospitalisation data. The study size of more than 160,000 subjects is enormous. The study is comprehensibly described and written in good English. Nevertheless, I do have some comments/questions:

Major

1. How do the authors explain the observation that older people (60-64 years) have lower PRs than people aged 50-55 years (see Fig 3)?

2. The data analysed are relatively old. How do the authors assess the transferability of the results to the present day? Could the results be influenced by the financial crisis of 2007-2008?

3. I stumble upon the number of subjects included. Perhaps the relevant section could be made clearer:

• In the abstract the subjects with CVD (19,137) and without CVD (144,294) do not add up to 163,562.

• Please give numbers of excluded subjects, e.g. for the retirees who had been classified as participating in the workforce (line 117).

• How large was the data set finally evaluated?

4. The references should be revised. For example, in some references the PID is given in others it is missing.

Minor

• Should „Language other than English (LOTE)“ describe the mother tongue? (Line 144) Please specify.

• Why were Australia and New Zealand combined when considering the place of birth (Line 144)?

• Please explain the basis for the categorisation of alcohol consumption. How were the cut-offs chosen? How was an alcoholic drink defined? (Lines 146-148)

• How were the cut-offs chosen for physical functioning limitations? (Lines 153-156)

• The information on the exclusion of persons without data regarding workforce participation should be given in the method section. Please specify how many subjects were excluded. (Lines 173/174)

• Table 1: What does „/“ stand for in the 3rd line (Percentage (%))?

• Inaccuracies in Table 2: It should be „[inter quartile range]“ and „To care for family“ should be shown left centred.

• Fig 1: Why do you mention SEM but do not show SEM?

Reviewer #2: Overall, the manuscript provides valuable information on CVD and workforce participation, based on a large sample size.

Please consider following comments:

1. The response rate should already be mentioned in the methods, briefly, and - if applicable - further aspects with regard to sample composition (weighting?, exclusions due to implausible questionnaires?).

2. Outcome measurement:

Full retirement definition was based on giving reasons for retirement, why not just use the information on current work status (“Completely retired/pensioner”)?

Current work status was indicated by multiple choice, did multiple choices occur and how was this handled then?

Participation in work was also defined by paid work hours including 0 hours?

3. I could not find the number of excluded participants with missing data on workforce participation (either text or flow chart).

4. There seems to be some truncated text in the two tables.

5. The overlap of workforce participation/retirement should not be considered in analysis retirement (line 116). Do the precentages in line 210/11 refer to this, though? Then it could also be included in table 2.

6. Line 281: The "and" in the middle should be "or"?

7. As the authors correctly state in the methods, causal relationships cannot be assessed in this study, though implicitly assumed at least in conclusions. Lines 289 ff seem to discuss possible causal relationships, but the paragraph needs more comprehensible and clear formulation. This should also include physical disablity.

8. I am not familiar with "PRs, which are based on internal comparisons" (line 324), what does this mean/what would be the opposite? Despite the reference44, I doubt that it is correct to negate any selection bias in the study. As education was used in the analysis (and is usually associated with CVD), how comparable was it to the general population?

9. As results for physical disablity are a "key finding", they should also be included in the conclusions.

10. "The results of this investigation have significant policy implications for healthy and successful ageing for those living with CVD." (line 339ff) I cannot follow this: What are the implications for health for people with CVD here?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Apr 8;16(4):e0249738. doi: 10.1371/journal.pone.0249738.r002

Author response to Decision Letter 0


9 Mar 2021

RESPONSE TO REVIEWERS’ COMMENTS

EDITOR'S COMMENTS

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

We have revised the manuscript to confirm with the requirement of the journal.

2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

We have added one paragraph in the cover letter to address the issue of data availability, including the restrictions on sharing a de-identified data, and the ways to access the data.

3. Thank you for stating the following in your Competing Interests section:

'None'

a. Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now

b. This information should be included in your cover letter; we will change the online submission form on your behalf.

Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests

In the cover letter above, we have stated about the grants received by authors, and declared that the authors have no other competing interests.

Reviewer #1:

The authors examined the relationship of cardiovascular disease to workforce participation in older working-age people. For this purpose they used questionnaire data from a very large population based study assessed between 2006 and 2009 in New South Wales (Australia) and linked it to hospitalisation data. The study size of more than 160,000 subjects is enormous. The study is comprehensibly described and written in good English. Nevertheless, I do have some comments/questions:

We thank the reviewer for recognising the importance of this work.

Major

1. How do the authors explain the observation that older people (60-64 years) have lower PRs than people aged 50-55 years (see Fig 3)?

The higher PR in the younger age group is not surprising. The PR is the prevalence (proportion) in the exposed divided by the prevalence in the unexposed (baseline) group. Thus, all else being equal, as the prevalence in the baseline group increases, the PR will decrease. Because the prevalence of (adverse) outcomes commonly increase with age, it is very common to see PRs decrease with age, as is the case here.

Crude prevalence (proportion) of workforce non-participation was higher in 60-64 year olds compared to 50-54 year olds, irrespective of CVD status; see the following extract from Fig 3.

Age-group Proportions (%) not in work PR (95% CI)

CVD group No CVD group

50-54 year 25.7 13.7 1.75 (1.65-1.84)

60-64 year 56.0 47.0 1.21 (1.19-1.24)

The following statement has been included in line 253 to 254 in the manuscript:

Although the crude prevalence of workforce non-participation was higher in older compared to younger age groups (irrespective of CVD status), the relation of CVD and workforce non-participation became weaker with increasing age.

2. The data analysed are relatively old. How do the authors assess the transferability of the results to the present day? Could the results be influenced by the financial crisis of 2007-2008?

Population distribution and cardiovascular disease profile in Australia have not drastically changed since these data were collected. Notably, the effect of the financial crisis of 2007-2008 on Australia has been considerably less than in many other countries (ABS, 2010). Regardless, the relative estimates (PRs) comparing those CVD vs without may well be transferable (Rothman et al., 2013). This is particularly so if the financial crisis or other factors have not affected workforce participation disproportionately based on CVD status, but this is unlikely.

Reference:

ABS (Australian Bureau of Statistics), The Global Financial Crisis and its impact on Australia, Year Book Australia 2009–10, Number 91, ABS Canberra, ABS Catalogue No. 1301.0, Chapter 27 — Financial system, 2010, p. 687-88.

Rothman KJ, Gallacher JE, Hatch EE. Why representativeness should be avoided. Int J Epidemiol. 2013 Aug;42(4):1012-4. doi: 10.1093/ije/dys223. PMID: 24062287

3. I stumble upon the number of subjects included. Perhaps the relevant section could be made clearer:

• In the abstract the subjects with CVD (19,137) and without CVD (144,294) do not add up to 163,562.

Thank you for identifying this. The final number of eligible participants was 163,562; this is the number of participants included in the descriptive tables. As outcome-specific exclusions for missing or invalid data were applied for each outcome, the number of participants contributing to regression models were slightly different: 163,431 for workforce participation, 114,064 for paid hours of work and 11,961 for retirement due to ill health. However, there was no missing value for retirement. We have modified the abstract, methods and study flow chart (Fig S1) to make this clearer.

• How large was the data set finally evaluated?

We have modified the abstract, methods and study flow chart (Fig S1) to make this clearer.

4. The references should be revised. For example, in some references the PID is given in others it is missing.

We have checked all references again, aiming to provide PIDs. However, not all references had a PID, hence it was not possible to provide a PID for all references. In the first draft, we used Endnote as reference manager but in this revised version the references were edited manually after unlinking those from the main body of the article.

Minor

• Should ‘Language other than English (LOTE)’ describe the mother tongue? (Line 144) Please specify.

The questionnaire asked ‘Do you speak a language other than English at home’ followed by two options to choose from (yes and no). To further clarify, the wording has been modified both in the text and in the table to ‘language spoken at home other than English (yes/no)’.

• Why were Australia and New Zealand combined when considering the place of birth (Line 144)?

New Zealand citizens do not need a visa to live or work in Australia and have access to most of the same entitlements, including health and welfare, and opportunities as Australian citizens. Hence, we grouped Australian and New Zealand citizens as one category and classified participants from other countries as others.

• Please explain the basis for the categorisation of alcohol consumption. How were the cut-offs chosen? How was an alcoholic drink defined? (Lines 146-148)

This variable was categorised with cut points (0, 1-14 and ≥15) aimed to align with the Australian alcohol consumption guidelines to minimise the risk of long-term harm. At the time of data collection, the guideline for low-risk alcohol consumption in Australia was daily consumption of 20 gram of alcohol and the standard drink was defined as 10 gram of alcohol. This meant 14 standard drinks per week was considered low-risk alcohol drink for both men and women in Australia at the time of data collection. The following text with reference is added in the ‘Other variables of interest section’ of main text of the manuscript.

The cut-points of alcohol consumption broadly reflect Australian guidelines on low-risk consumption [33].

References

33. NHMRC (National Health and Medical Research Council). Australian Guidelines To Reduce Health Risks From Drinking Alcohol (NHMRC, Canberra, 2009).

• How were the cut-offs chosen for physical functioning limitations? (Lines 153-156)

We have added a reference for the choice of cut points for physical functioning limitations. The manuscript now reads:

Physical functioning limitations scores ranged from 0 to 100, with higher scores representing fewer limitations, and were grouped into four categories: no limitation (score of 100); minor limitation (score 90–99); moderate limitation (60–89); and severe limitation (score 0–59) [35]

35. Stewart A, Kamberg C. Measuring functioning and well-being: the Medical Outcomes Study Approach.Durham, North Carolina: Duke University Press; 1992

Further details are provided in Supplementary Table S6.

• The information on the exclusion of persons without data regarding workforce participation should be given in the method section. Please specify how many subjects were excluded. (Lines 173/174)

We have updated the methods section of the manuscript to clarify the definition. The following paragraph has been added to the end of ‘Study population and data sources’.

The participants with invalid data on age or date of recruitment (n=454), those with linkage errors (n=195) and those aged 65 years or over (n=102,942) were excluded. There were 163,562 participants who were of working age (45-<65 years old) with known CVD status at baseline (70 458 men, 93 104 female) (details in supplementary file: S1-S4 Figs, S1-S3 Tables).

At the end of ‘Outcome: Workforce participation’ section, the following statement regarding the number of participants excluded is added.

Outcome-specific exclusions for missing or invalid data were applied for each outcome. Of the 163,562 participants included in the study, 131 had missing data on workforce participation status (Supplementary Fig1). Of the 121,816 participants in the work force, 7752 had missing/invalid data on the number of paid hours per week. Of the 41,615 participants not in the work force, 11,961 had invalid data on retirement due to ill health.

• Table 1: What does „/“ stand for in the 3rd line (Percentage (%))?

This section in the table is revised to ‘/163562’ in both columns.

• Inaccuracies in Table 2: It should be „[inter quartile range]“ and „To care for family“ should be shown left centred.

We have updated Table 2.

• Fig 1: Why do you mention SEM but do not show SEM?

The value is very small and thus might not be always visible. A new note ‘‘, and SEM might not be always visible because of small values’’ is embedded in Figure 2. The mean and standard error of mean (SEM) of paid work hours per week according to CVD, age-group are presented for ‘men and women combined’, men and women. These values were used to generate the bar diagram presented in the paper. The mean values were rounded while printing those on top of the figure but while making the bar height, the values upto 5 decimal points were used.

Reviewer #2:

Overall, the manuscript provides valuable information on CVD and workforce participation, based on a large sample size.

We thank the reviewer for recognising the importance of this work.

Please consider following comments:

1. The response rate should already be mentioned in the methods, briefly, and - if applicable - further aspects with regard to sample composition (weighting?, exclusions due to implausible questionnaires?).

A detailed description of the 45 and Up study is available as part of a published protocol (Banks et al,. International journal of epidemiology. 2008;37(5):941-7. doi: 10.1093/ije/dym184) so we did not extensively describe it in this paper. However, we have added in further details on the response rate, weighting and exclusion criteria to the revised manuscript. The newly added texts in the ‘Study population and data sources’ section are as follows:

Individuals joined the study by completing a postal questionnaire (available at https://www.saxinstitute.org.au/our-work/45-up-study/questionnaires/) and providing consent for follow-up through linkage to a range of routinely-collected data. The majority of participants joined in 2008, with the majority completing the baseline questionnaire in February 2008. Persons aged 80 years and over and those living in rural and remote areas were oversampled by a factor of two. The response rate to mailed invitations was estimated to be 18%, with the final sample representing around 10% of the NSW population aged 45 years and older.

The participants with invalid data on age or date of recruitment (n=454), those with linkage errors (n=195) and those aged 65 years or over (n=102,942) were excluded. There were 163,562 participants who were of working age (45-<65 years old) with known CVD status at baseline (70 458 men, 93 104 female) (details in supplementary file: S1-S4 Figs, S1-S3 Tables).

2. Outcome measurement:

Full retirement definition was based on giving reasons for retirement, why not just use the information on current work status (“Completely retired/pensioner”)?

Most participants chose more than one option from the multiple-choice questions that asked about current work status and many were found to be in apparent conflict regarding retirement status. On the other hand, defining retirement status from the questionnaire that asked about the cause of retirement was straight forward. Note we have used the term ‘retired’, and have not differentiated between ‘full-retirement’ or ‘partial retirement’.

Current work status was indicated by multiple choice, did multiple choices occur and how was this handled then? Participation in work was also defined by paid work hours including 0 hours?

Yes, there were participants choosing more than one option from the multiple-choice questions. Logical checks were done using responses to questions on current work status and ‘paid work hours per week’. We have made this clearer in the revised manuscript (first paragraph of the section ‘Outcomes: Workforce participation’ in page 6). The steps of defining workforce participation might explain further how paid work hours per week contributed to the definition of workforce participation, and how inconsistencies between paid work status and paid work hour per week were resolved. The following text is added in the supplementary section in S4 Table.

• Participants were considered to be in paid work if:

o Number of hours of paid work hours is valid (0 to <100) OR

o Reported being in full time paid work, in part time paid work, self-employed or partially retired.

• Participants were considered to be not in paid work if:

o Number of hours of paid work hours per week is zero (0) or missing (but not invalid) AND

o Not reported being in fulltime paid work, part time paid work, self-employed or partially retired

• People who are not paid for work automatically received zero (0) for paid work hour per week

• For those who are in “paid” category and entered 0 as paid work hour per week, their paid work status was accepted, and weekly paid work hours were invalidated

• For those who are in “not paid” category and entered valid paid work hours per week, their paid work status was changed, and weekly paid work hours were accepted when the weekly paid work hours were larger than 0.

3. I could not find the number of excluded participants with missing data on workforce participation (either text or flow chart).

The proportion is mentioned at the footnote of Table 2. The exact numbers are now mentioned in response to first reviewer’s query number 3 as above and also, in the supplementary file (S1-S4 Figs and S1-S3 Tables).

4. There seems to be some truncated text in the two tables.

We have updated the both tables.

5. The overlap of workforce participation/retirement should not be considered in analysis retirement (line 116). Do the precentages in line 210/11 refer to this, though? Then it could also be included in table 2.

This has been updated and the exact numbers are now mentioned in the text with relevant wordings. It was explained in query 3 of first reviewer, and further details are provided in the supplementary file (S1-S4 Figs and S1-S3 Tables).

6. Line 281: The "and" in the middle should be "or"?

We have updated this sentence and now in line 295 in the clean version.

7. As the authors correctly state in the methods, causal relationships cannot be assessed in this study, though implicitly assumed at least in conclusions. Lines 289 ff seem to discuss possible causal relationships, but the paragraph needs more comprehensible and clear formulation. This should also include physical disablity.

This paragraph has been updated and includes the issue of physical disability as a possible underlying mechanism which is further explained in the paragraph that follows it. The wording is as follows:

Another underlying reason for higher workforce non-participation in people with CVD could be physical disability since physical functioning has been shown to decline following incident CVD [41] and this study has indicated that those with higher physical functioning limitations had the highest probability of being out of paid-work.

Reference:

41. Kucharska-Newton A, Griswold M, Yao ZH, Foraker R, Rose K, Rosamond W, et al. Cardiovascular Disease and Patterns of Change in Functional Status Over 15 Years: Findings From the Atherosclerosis Risk in Communities (ARIC) Study. J Am Heart Assoc. 2017;6(3):e004144. pmid: 28249844.

8. I am not familiar with "PRs, which are based on internal comparisons" (line 324), what does this mean/what would be the opposite? Despite the reference44, I doubt that it is correct to negate any selection bias in the study. As education was used in the analysis (and is usually associated with CVD), how comparable was it to the general population?

The ratio of prevalences of two groups is called prevalence ratio (PR), and it is analogous to the risk ratio (RR) in cohort studies. Although the absolute proportions estimated in this study will likely not reflect the absolute numbers in the target population, it is reasonable to assume that the relative comparison between groups (in this case the PRs of CVD compared to non-CVD) will be similar in the target population if confounding is minimised (see also response to Reviewer 1, point 2). We have acknowledged the possibility of selection bias but also emphasised the strength of findings from internal comparison in this investigation. The wording of the sentence is now updated as follows:

Hence, while our absolute estimates of CVD prevalence and workforce participation may not be generalisable, PRs, which are based on internal comparisons, are still likely to be generalisable [47].

47. Mealing NM, Banks E, Jorm LR, Steel DG, Clements MS, Rogers KD. Investigation of relative risk estimates from studies of the same population with contrasting response rates and designs. BMC Med Res Methodol. 2010;10:26. pmid: 20356408

We sought to look for other comparable studies but could not find any that investigated the association of CVD, workforce participation and education among study participants similar to ours.

9. As results for physical disablity are a "key finding", they should also be included in the conclusions.

The issue of physical disability was previously mentioned at the end of the sentence (in line 337 of the old version and line 409 of the new version). Now in this version we have deleted the end section of that sentence and added a new sentence stating it as a key finding in the conclusion (in line 362-363 of new clean version), which is as follows.

Physical functioning limitations was a key factor in non-participation in the paid workforce both for those with and without CVD.

10. "The results of this investigation have significant policy implications for healthy and successful ageing for those living with CVD." (line 339ff) I cannot follow this: What are the implications for health for people with CVD here?

The following text is added at the end of the discussion section to clarify the implications (last section of the final paragraph of the discussion section).

Our results show the majority of people with CVD were still in the paid workforce but people who experienced a CVD event, especially those with physical disability, were more vulnerable to not being in the workforce compared to their counterparts. Given the importance of paid work for individual wellbeing and the overall economy [15], policies aimed at helping people with CVD, particularly those with accompanying physical disability, to remain or re-enter the workforce would be of benefit to both individuals and society.

Reference:

15. Schofield D, Shrestha R, Percival R, Passey M, Callander E, Kelly S. The personal and national costs of CVD: impacts on income, taxes, government support payments and GDP due to lost labour force participation. Int J Cardiol. 2013;166(1):68-71. pmid: 22018513.

EDITOR'S COMMENTS

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

We agree to publish the full peer review history.

With best wishes,

Yours sincerely,

Muhammad Shahdaat Bin Sayeed, on behalf of the authors

ORCID ID: 0000-0003-0027-9614

Attachment

Submitted filename: ResponseLetter_PONE-D-20-33041_15Jan2021.docx

Decision Letter 1

Thomas Behrens

24 Mar 2021

Cardiovascular disease subtypes, physical disability and workforce participation: a cross-sectional study of 163,562 middle-aged Australians

PONE-D-20-33041R1

Dear Dr. Bin Sayeed,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Thomas Behrens

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I enjoyed reading the revised manuscript and the answers to my questions. All my questions were answered to my complete satisfaction. I have no further comments.

I thank the authors for this valuable work.

Reviewer #2: All comments have been adressed. An additional minor recommendation is to use thousands seperators in the tables, too.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Acceptance letter

Thomas Behrens

30 Mar 2021

PONE-D-20-33041R1

Cardiovascular disease subtypes, physical disability and workforce participation: a cross-sectional study of 163,562 middle-aged Australians

Dear Dr. Bin Sayeed:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Thomas Behrens

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File

    (DOCX)

    Attachment

    Submitted filename: ResponseLetter_PONE-D-20-33041_15Jan2021.docx

    Data Availability Statement

    This study uses data from the 45 and Up Study, which is managed by the Sax Institute in collaboration with major partner Cancer Council NSW, and partners: the National Heart Foundation of Australia (NSW Division); NSW Ministry of Health; NSW Government Family & Community Services–Ageing, Carers and the Disability Council NSW; and the Australian Red Cross Blood Service. Data supporting the findings from this study are available from the Sax Institute, the NSW Department of Health and the Australian Bureau of Statistics, with data linkage conducted by the NSW Centre for Health Record Linkage. Restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Researchers may apply for access to these data with the appropriate data custodian and ethics approvals. Information about data access and governance policies is available at: https://www.saxinstitute.org.au/our-work/45-up-study/for-researchers/.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES